Biography
Luca’s experience encompasses a broad range of industries and business sectors, including industrial/manufacturing sectors, pharmaceuticals, energy, aviation, transportation and logistics, as well as technology.
Prior to joining Weil, Luca was a Senior Antitrust Counsel at Europe's leading online platform for fashion and lifestyle, and a senior associate at a US firm in Brussels (where he was seconded to a global footwear and apparel manufacturer as antitrust counsel). Luca also completed a traineeship at the European Commission DG Competition.
Representative experience includes acting for:*
- Fox Corporation, a multinational mass media company, in its acquisition of Roku, Inc. for approximately $22 billion
- Global Infrastructure Partners (GIP), a part of BlackRock, on its acquisition of TCR, the world’s largest independent lessor of airport ground support equipment, from 3i Infrastructure plc., before multiple antitrust and FDI agencies globally
- Lone Star Funds on several, recent transactions before multiple antitrust and FDI agencies globally, including:
- Its acquisition of ContiTech, the material solutions group of Continental AG, for approx. €4.0 billion;
- Its acquisition of DOMO Engineered Materials in a rare, conditional derogation decision from the EU Merger Regulation’s suspension obligations;
- Its disposal of Xella Group to Holcim in one out of only a handful of conditional Phase 1 European Commission approvals in 2026; and
- Its acquisition of RadiciGroup
- XSYS in its acquisition of MacDermid Graphics Solutions in one of the first CMA approvals to-date on the basis of the updated guidance on the de minimis exception
- Hitachi on its approximately USD 11 billion acquisition of ABB's power grid business.
- Abbott Laboratories on its USD 5.8 billion acquisition of Alere, Inc. securing conditional Phase 1 approval.
- An industrial equipment manufacturer on a global antitrust and ABC compliance audit in relation to suspected cartel.
- Chr. Hansen on the sale of its NCD division.
- Galapagos NV on its approximately USD 5.1 collaboration with Gilead Sciences Inc.
- GSK on a number of significant transactions, including its:
- USD 500 million divestment of its cephalosporin business (global) and related manufacturing and supply arrangements.
- Disposal of its manufacturing facilities in Verona (Italy) to ACS Dobfar.
- Camso on its EUR 1.7 billion acquisition by Michelin.
- FedEx in its EUR 4.4 billion acquisition of TNT Express.
(*including from previous firm)
Luca regularly advises on merger control and FDI implications of debt-to-equity conversions, primarily in the context of ad hoc groups of bondholders in distressed situations.